Albumin use guidelines and outcome in a surgical intensive care unit

Archives of Surgery

Volumn 143, Issue 10, 2008, Pages 935-939

  Charles, Anthony ^a   Purtill, Maryanne ^a   Dickinson, Sharon ^a   Kraft, Michael ^a   Pleva, Melissa ^a   Meldrum, Craig ^a   Napolitano, Lena ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; APACHE; ARTICLE; COHORT ANALYSIS; COST CONTROL; DATA BASE; DRUG COST; DRUG USE; FEMALE; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NURSING STAFF; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESIDENT; RESUSCITATION; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURGICAL WARD;

ALBUMINS; APACHE; COHORT STUDIES; COST SAVINGS; CRITICAL CARE; FEMALE; FLUID THERAPY; FOLLOW-UP STUDIES; GENERAL SURGERY; HOSPITAL COSTS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; PROBABILITY; PROSPECTIVE STUDIES; RESUSCITATION; RISK ASSESSMENT;

EID: 54349094014     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.143.10.935     Document Type: Article

References (37)

1. Choi PT, Yip G, Quinonez LG, Cook DJ. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med. 1999;27(1):200-210.
2. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomized trials. BMJ. 1998;316(7136):961-964.
3. Groeneveld AB. Albumin and artificial colloids in fluid management: where does the clinical evidence of their utility stand? Crit Care. 2000;4(suppl 2):S16-S20.
4. McClelland DB. Human albumin solutions. BMJ. 1990;300(6716):35-37.
5. Vincent JL, Wilkes MM, Navickis RJ. Safety of human albumin-serious adverse events reported worldwide in 1998-2000. Br J Anaesth. 2003;91(5):625-630.
6. Vincent JL, Dubois MJ, Navickis RJ, Willkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? a meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237(3):319-334.
7. Boldt J. The good, the bad, and the ugly: should we completely banish human albumin from our intensive care units? Anesth Analg. 2000;91(4):887-895.
8. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247-2256.
9. Pettilä V, Ruokonen E. Albumin has no benefit over saline in the critically ill. Acta Anaesthesiol Scand. 2005;49(5):599-600.
10. University Hospital Consortium (UHC) Clinical Practice Technology Advancement Center. Technology Support: Results of the Albumin and Nonprotein Colloid Solutions Multicenter Technology Use Surveillance. Oakbrook, IL: University Health System Consortium; May 2000.
11. Vermeulen LC, Ratko TA, Erstad BL, Brecher ME, Matuszewski KA. A paradigm for consensus: the University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med. 1995;155(4):373-379.
12. Yim JM, Vermeulen LC, Erstad BL, Matuszewski KA, Burnett DA, Vlasses PH. Albumin and nonprotein colloid solution use in US academic health centers. Arch Intern Med. 1995;155(22):2450-2455.
13. Roberts I, Alderson P, Bunn F, et al. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2004;(4):CD000567.
14. Lucas CE. The water of life: a century of confusion [The Scudder Oration, Clinical Congress of the American College of Surgeons, October 2000]. J Am Coll Surg. 2001;192(1):86-92.
15. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomized controlled trials. BMJ. 1998;317(7153):235-240.
16. Offringa M. Excess mortality after human albumin administration in critically ill patients: clinical and pathophysiological evidence suggests albumin is harmful. BMJ. 1998;317(7153):223-224.
17. Wilkes MM, Navickis RJ. Patient survival after human albumin administration: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2001;135(3):149-164.
18. Alderson P, Bunn F, Lefebvre C, et al. Albumin reviewers: human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2004;(4):CD001208.
19. Margarson MP, Soni NC. Changes in serum albumin concentration and volume expanding effects following a bolus of albumin 20% in septic patients. Br J Anaesth. 2004;92(6):821-826.
20. Finfer S, Bellomo R, McEvoy S, et al; SAFE Study Investigators. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of the data from the saline versus albumin fluid evaluation (SAFE) study. BMJ. 2006;333(7577):1044-1049.
21. Primack WA, Estes K. Fluid resuscitation in the intensive care unit. NEngl J Med. 2004;351(18):1905-1908.
22. Cook D. Is albumin safe? [editorial]. N Engl J Med. 2004;350(22):2294-2296.
23. Vincent JL, Sakr Y, Reinhart K, Sprung CL, Gerlach H, Ranieri VM; Sepsis Occurrence in Acutely Ill Patients' Investigators. Is albumin administration in the acutely ill associated with increased mortality? results of the SOAP study. Crit Care. 2005;9(6):R745-R754.
24. Berger A. Why albumin may not work. BMJ. 1998;317(7153):240.
25. Osband AJ, Deitch EA, Hauser CJ, et al. Albumin protects against gut-induced lung injury in vitro and in vivo. Ann Surg. 2004;240(2):331-339.
26. Martin GS, Magialardi RJ, Wheller AP, et al. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med. 2002;30(10):2175-2182.
27. Martin GS, Moss M, Wheeler AP, et al. A randomized controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med. 2005;33(8):1681-1687.
28. Evans TW. Albumin as a drug-biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther. 2002;16(suppl 5):6-11.
29. Suarez JI, Shannon L, Zaidat OO, et al. Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage. J Neurosurg. 2004;100(4):585-590.
30. Early Albumin Resuscitation During Septic Shock http://www. clinicaltrials.gov/ct/show/NCT00327704. Accessed May 29, 2007.
31. Albumin in Acute Ischemic Stroke (ALIAS) Trial http://www.clinicaltrials. gov/ct/show/NCT00235495. Accessed May 29, 2007.
32. Treatment of Subarachnoid Hemorrhage With Human Albumin http://www.clinicaltrials.gov/ct/show/NCT00283400. Accessed May 29, 2007.
33. Fan C, Phillips K, Selin S. Serum albumin: new thoughts on an old treatment. BCMJ. 2005;47(8):438-444.
34. Sedrakyan A, Gondek K, Paltiel D, Elefteriades JA. Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery. Chest. 2003;123(6):1853-1857.
35. Cooper AB, Cohn SM, Zhang HS, et al; ALBUR Investigators. Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction. Transfusion. 2006;46(1):80-89.
36. Greenhalgh DG, Housinger TA, Kagan RJ, et al. Maintenance of serum albumin levels in pediatric burn patients: a prospective, randomized trial. J Trauma. 1995;39(1):67-74.
37. Tanzi M, Gardner M, Megellas M, et al. Evaluation of the appropriate use of albumin in adult and pediatric patients. Am J Health Syst Pharm. 2003;60(13):1330-1335.